PUBLIC COMPANY
save$INDVIndivior Pharmaceuticals, Inc.
$INDV38.38-1.70%North Chesterfield, VA, USupdated 2h ago
community read0 votes
pipeline
4
marketed
1
phase 3
0
catalysts ytd
2
approvals ytd
0
recalls ytd
0
Pipeline(4)
pipeline depth4 products
1Phase 21Marketed2Unknown
Marketed
buprenorphine LA
Opium (Opioid) Addiction
Phase 2rocavorexant
Opium (Opioid) Addiction
drugSUBLOCADE
1 INDICATIONS AND USAGE SUBLOCADE is indicated for the tr…
Kappa-type opioid receptorMu-type opioid receptor
drugSUBOXONE
1 INDICATIONS AND USAGE SUBOXONE sublingual film is indic…
Kappa-type opioid receptorMu-type opioid receptor
Upcoming
no upcoming catalysts on record
Recent(90d)
earnings (1)
Active trials
- phase2INDV-6001 Multiple-Dose Pharmacokinetic Study
- phase4Buprenorphine Extended-Release Subcutaneous Injection (RBP-6000) in High-risk Users
- —Evaluating the SUBLOCADE Treatment Exit Strategy
- phase2Proof of Concept and Dose-ranging Study of INDV-2000 in Individuals With Moderate to Severe Opioid Use Disorder
- —SUBLOCADE Long-term Outcomes
- —A Study To Assess The Feasibility Of Indivi Mobile Application In Monitoring Cognitive Performance In Aging Population
- phase4SUBLOCADE Rapid Initiation Extension Study
- phase4SUBLOCADE Rapid Initiation Study
Insider activity
source: SEC Form 4open-market buys + sells
routine RSU / option mechanics (6)
- Mar 14, 26tax coverPreblick Ryan · Chief Financial Officer2,843 sh
- Mar 14, 26option exercisePreblick Ryan · Chief Financial Officer6,302 sh
- Mar 14, 26option exercisePreblick Ryan · Chief Financial Officer6,302 sh
- Mar 3, 26tax coverPreblick Ryan · Chief Financial Officer87,597 sh
- Mar 3, 26tax coverHeidbreder Christian · Chief Scientific Officer45,797 sh
- Mar 3, 26tax coverBurris Jeffrey W · Chief Legal Officer36,032 sh
🐶 Hiring Signal
News
no news has mentioned this company yet
Data sources
last refreshed 6m ago
Found something off?
comments(0)
5-min edit window · permanent after that